1. Home
  2. AMRX vs LNTH Comparison

AMRX vs LNTH Comparison

Compare AMRX & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

SELL

Current Price

$21.23

Market Cap

6.4B

Sector

Health Care

ML Signal

SELL

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

SELL

Current Price

$101.75

Market Cap

6.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
AMRX
LNTH
Founded
2002
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.5B
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
AMRX
LNTH
Price
$21.23
$101.75
Analyst Decision
Strong Buy
Hold
Analyst Count
7
9
Target Price
$24.29
★ $105.99
AVG Volume (30 Days)
★ 3.5M
954.9K
Earning Date
11-03-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 157.89
N/A
EPS
0.29
★ 3.21
Revenue
N/A
★ $343,374,000.00
Revenue This Year
$6.38
$0.40
Revenue Next Year
$9.21
$8.23
P/E Ratio
$73.78
★ $31.66
Revenue Growth
N/A
★ 3.62
52 Week Low
$11.39
$51.84
52 Week High
$22.07
$111.86

Technical Indicators

Market Signals
Indicator
AMRX
LNTH
Relative Strength Index (RSI) 57.02 64.76
Support Level $18.90 $99.84
Resistance Level $21.21 $102.66
Average True Range (ATR) 0.86 0.46
MACD 0.04 0.13
Stochastic Oscillator 71.96 93.98

Price Performance

Historical Comparison
AMRX
LNTH

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: